deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT04089215

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

A Phase II Open-Label, Single-Arm, Multicenter Study of JWCAR029, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.

Conditions Diffuse Large B Cell Lymphoma Follicular Lymphoma Lymphoma, Non-Hodgkin
Interventions CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
Updated 7 times since 2019 Last updated: Nov 21, 2023 Started: Jun 11, 2019 Primary completion: Sep 10, 2021 Completion: Sep 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04089215, this PHASE2 trial focuses on Diffuse Large B Cell Lymphoma and Follicular Lymphoma and remains ongoing. Sponsored by Shanghai Ming Ju Biotechnology Co., Ltd., it has been updated 7 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotRecruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotRecruiting~Feb 2021 – ~Dec 2023 · 34 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshotActive Not Recruiting~Jan 2026 – present · 6 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Jan 2026 — Present [monthly]

    Unknown PHASE2

    Status: Active Not Recruiting → Unknown

  2. Sep 2024 — Jan 2026 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Dec 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Feb 2021 — Dec 2023 [monthly]

    Recruiting PHASE2

▶ Show 2 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  2. Oct 2019 — Jan 2021 [monthly]

    Recruiting PHASE2

    First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shanghai Ming Ju Biotechnology Co., Ltd.
Data source: Shanghai Ming Ju Biotechnology Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations